We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cancer Development Linked to Faulty Gene Repair Mechanism

By Biotechdaily staff writers
Posted on 20 Jan 2003
Researchers studying the role of DNA repair as a factor in cancer development have found evidence that the BLM gene helps to thwart cancer by maintaining genomic stability through promotion of efficient DNA repair, which prevents double-strand break repair by less precise pathways. Their findings were reported in the January 10, 2003, issue of Science.

An autosomal recessive mutation of the BLM gene causes Bloom syndrome, a rare disorder in which sufferers exhibit an extremely high incidence of cancer in many tissues. In addition to being highly cancer-prone, children born with the syndrome are short throughout their lives, sterile, and have poorly functioning immune systems.

To study the disorder, researchers from the University of North Carolina (Chapel Hill, USA) have worked with a Drosophila model lacking BLM.

Previous research suggested that Drosophila BLM functioned in the repair of DNA double-strand breaks. Most double-strand breaks in flies are repaired by homologous recombination through the synthesis-dependent strand-annealing pathway. The mutant flies no longer have this repair mechanism. In the current study, the investigators found that repair in the mutants was completed by error-prone pathways that created large deletions. This finding suggests that BLM does maintain genomic stability by promoting efficient DNA repair and preventing double-strand break repair by less precise pathways.

"We feel that our results represent a substantial step forward in understanding this important DNA repair gene,” explained senior author Dr. Jeff Sekelsky, assistant professor of biology at the University of North Carolina. "This will aid in our understanding of Bloom syndrome, DNA repair pathways and, perhaps most importantly, cellular defects that lead to cancer.”



Related Links:
University of North Carolina

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Total Laboratory Automation Solution
SATLARS Mini T8

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
20 Jan 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
20 Jan 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
20 Jan 2003  |   BioResearch